Oncopeptides AB (publ) (LON:0RN4)
1.950
+0.034 (1.75%)
At close: Apr 25, 2025
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 33.91 million as of April 25, 2025. Its market cap has decreased by -2.45% in one year.
Market Cap
33.91M
Enterprise Value
29.52M
Revenue
2.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.95
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 33.91M, a decrease of -77.25%. That is a compound annual growth rate of -16.57%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 161.95B |
Shell | 147.12B |
HSBC Holdings | 145.16B |
Unilever | 119.58B |
Rio Tinto Group | 78.33B |
RELX PLC | 73.06B |
British American Tobacco p.l.c. | 69.71B |
Rolls-Royce Holdings | 61.54B |